B-MS Aligns Operations In China
Bristol-Myers Squibb is setting up a new organization in China in order to align its business operations in the country and maximize the company's overall potential in China. The organization is to be headed by Jack Wolinetz who will take up the newly-created position of president, China, Bristol-Myers Squibb.
B-MS first entered China in 1985 (see also page 5); its pharmaceutical arm, Sino-American Shanghai Squibb - a joint venture - was established in that year. In June this year Squibb ConvaTec Medical Products, also a joint venture, opened its first manufacturing plant in Shenzhen to produce ostomy care products.
The company plans to introduce personal care products to the region, including skin care products and hair products.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze